Literature DB >> 16857784

Inhibition of transforming growth factor-beta signaling in human cancer: targeting a tumor suppressor network as a therapeutic strategy.

Swati Biswas1, Tracy L Criswell, Shizhen Emily Wang, Carlos L Arteaga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16857784     DOI： 10.1158/1078-0432.CCR-06-0952

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  23 in total

1.  In vivo RNA interference of a gonad-specific transforming growth factor-β in the Pacific oyster Crassostrea gigas.

Authors:  Arnaud Huvet; Elodie Fleury; Charlotte Corporeau; Virgile Quillien; Jean Yves Daniel; Guillaume Riviere; Pierre Boudry; Caroline Fabioux
Journal:  Mar Biotechnol (NY)       Date:  2011-12-07       Impact factor: 3.619

2.  A functional study of transforming growth factor-beta from the gonad of Pacific oyster Crassostrea gigas.

Authors:  Charlotte Corporeau; Agnès Groisillier; Alexandra Jeudy; Tristan Barbeyron; Elodie Fleury; Caroline Fabioux; Mirjam Czjzek; Arnaud Huvet
Journal:  Mar Biotechnol (NY)       Date:  2011-01-27       Impact factor: 3.619

3.  TGFβ-dependent induction of interleukin-11 and interleukin-8 involves SMAD and p38 MAPK pathways in breast tumor models with varied bone metastases potential.

Authors:  Janhavi Gupta; John Robbins; Tamas Jilling; Prem Seth
Journal:  Cancer Biol Ther       Date:  2011-02-01       Impact factor: 4.742

Review 4.  Therapeutic targeting of the prostate cancer microenvironment.

Authors:  Maria Karlou; Vassiliki Tzelepi; Eleni Efstathiou
Journal:  Nat Rev Urol       Date:  2010-09       Impact factor: 14.432

Review 5.  Perspectives on tissue interactions in development and disease.

Authors:  D W Strand; O E Franco; D Basanta; A R A Anderson; S W Hayward
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

6.  Oncolytic adenovirus expressing soluble TGFβ receptor II-Fc-mediated inhibition of established bone metastases: a safe and effective systemic therapeutic approach for breast cancer.

Authors:  Zebin Hu; Helen Gerseny; Zhenwei Zhang; Yun-Ju Chen; Arthur Berg; Zhiling Zhang; Stuart Stock; Prem Seth
Journal:  Mol Ther       Date:  2011-06-28       Impact factor: 11.454

7.  Integral role of platelet-derived growth factor in mediating transforming growth factor-β1-dependent mesenchymal stem cell stiffening.

Authors:  Deepraj Ghosh; Loukia Lili; Daniel J McGrail; Lilya V Matyunina; John F McDonald; Michelle R Dawson
Journal:  Stem Cells Dev       Date:  2013-11-08       Impact factor: 3.272

8.  Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells.

Authors:  L Sauer; D Gitenay; C Vo; V T Baron
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

9.  TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells.

Authors:  Rossana Trotta; Jessica Dal Col; Jianhua Yu; David Ciarlariello; Brittany Thomas; Xiaoli Zhang; Jeffrey Allard; Min Wei; Hsiaoyin Mao; John C Byrd; Danilo Perrotti; Michael A Caligiuri
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 10.  Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?

Authors:  Antoinette R Tan; Gabriela Alexe; Michael Reiss
Journal:  Breast Cancer Res Treat       Date:  2008-10-09       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.